Navigation Links
Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
Date:8/28/2007

- Payment to be received in September 2007 for successful completion of

Phase 2b clinical trial -

ROCKVILLE, Md., Aug. 28 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc., (Nasdaq: HGSI) today announced that it will receive a $40 million payment from Novartis in September 2007 for the previously reported successful completion of a Phase 2b trial of Albuferon(R) (albinterferon alfa-2b) in treatment-naive patients with chronic hepatitis C.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"This $40 million payment will bring the total milestone payments received from Novartis under our Albuferon co-development and commercialization agreement to $132.5 million," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "Novartis and HGS are also sharing clinical development costs equally. From a strategic perspective, our collaboration with Novartis is proceeding very well. Our companies are jointly committed to the highest quality of clinical development, and we are working closely together to bring Albuferon to market as rapidly as possible."

HGS also reported in a separate press release issued earlier today that it has completed enrollment ahead of schedule in the first of two pivotal Phase 3 trials of Albuferon in chronic hepatitis C, and now expects to have Phase 3 data available by the spring of 2009, with filing of global marketing authorization applications anticipated by the fall of 2009.

Under a co-development and commercialization agreement entered into in June 2006, HGS and Novartis will co-commercialize Albuferon in the United States and will shar
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... to be able to charge their cell phones and other ...recent discovery made by UC San Diego engineers co...that could do just this. , In recent research, ...Bandaru, a professor in the UCSD Department of Mec...uate student Mark Hoefer, have found that artifici...
(Date:11/19/2009)...19 NeoStem, Inc. (NYSE A...following letter to its shareholders, discussing t...China Biopharmaceuticals Holdings, Inc. (CHBP), an...e People,s Republic of China. The merger gives Neo...rmaceutical Co. Ltd., CHBP,s primary operating sub...
(Date:11/19/2009)...Top LASIK surgeons and recognized refractive and c...rgeons made brought their fellow surgeons up-to-da... surgery, cataract surgery, and ophthalmology in g...of Ophthalmology (AAO) annual meeting in San Franc...ar Tauber, Dr. David Huang, MD, Dr. Randy Epstein,...
(Date:11/18/2009)...l Institute of Standards and Technology (NIST) has...hod for detecting and measuring elusive hazards su...poilage in food or pesticides distributed in soil ...sitive than conventional techniques for detecting ...er molecules, having distinct electrically positiv...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Prototype NIST method detects and measures elusive hazards 2
... May 7 Cadence Pharmaceuticals, Inc. (Nasdaq: C...icensing, developing and commercializing proprieta...ospital setting, today reported financial results ...We have now completed the clinical development pro...on of intravenous acetaminophen for the treatment ...
...Calif., May 7 AutoImmune Inc. (OTC Bulletin Board...$0.01 per share basic and diluted, for the three m...ss of $107,000, or $0.01 per share basic and dilut... of March 31, 2009, the Company reported $8.5 mill...ount reported as of December 31, 2008. , , Chair...
...eeded to train workforce, stimulate economy , , ...eiled its Fiscal Year 2010 budget request, proposi...d Technical Education Act (Perkins Act) at $1.3 bi...deral funding that supports local education progra...The Association for Career and Technical Education...
Other Biology Technology:Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 2Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 3Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 4Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 5Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 6Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 7AutoImmune Inc. Reports 2009 First Quarter Financial Results 2AutoImmune Inc. Reports 2009 First Quarter Financial Results 3AutoImmune Inc. Reports 2009 First Quarter Financial Results 4Obama Budget Level Funds Career Technical Education 2Obama Budget Level Funds Career Technical Education 3
(Date:11/19/2009)...ate fungus for food, have many remarkable qualitie...nt farmers, like their human counterparts, depend ...grow. The finding, reported this week (Nov. 20) in...nown symbiosis between ants and bacteria and provi... dominate the American tropics and subtropics. , ...
(Date:11/19/2009)... multi-institutional effort co-led by three Cold S...ed today in publication of a landmark series of pa...dented detail the DNA sequence of maize ( Zea mays...rth American consumers, is one of the world,s most...al crop grown in the United States, representing $...
(Date:11/19/2009)...ainable farming, initially adopted to preserve soi...role in maintaining a healthy climate, according t...dge and Los Alamos national laboratories. , ORNL...tial of the earth,s soils to sequester carbon, wit...ould greatly reduce U.S. carbon emissions by as mu...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Sex Hormone Protein May Predict Type 2 Diabetes 53775 1Sex Hormone Protein May Predict Type 2 Diabetes 53775 2Sex Hormone Protein May Predict Type 2 Diabetes 53775 3PDI Reports 2009 Second Quarter Financial Results 13399 1PDI Reports 2009 Second Quarter Financial Results 13399 2PDI Reports 2009 Second Quarter Financial Results 13399 3PDI Reports 2009 Second Quarter Financial Results 13399 4PDI Reports 2009 Second Quarter Financial Results 13399 5PDI Reports 2009 Second Quarter Financial Results 13399 6PDI Reports 2009 Second Quarter Financial Results 13399 7PDI Reports 2009 Second Quarter Financial Results 13399 8PDI Reports 2009 Second Quarter Financial Results 13399 9Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 1Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 2Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 3Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 4Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 5Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 6Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 7
... regulatory gene that shows clear evidence of evol... evolution of humans might well have depended in p...rphin (PDYN), that plays critical roles in regulat...ed that, compared to lower primates, humans posses... the prodynorphin gene, which is a precursor molec...
...rnal of Experimental Medicine identifies a small g...g active tuberculosis (TB). Pedro Flores-Villanue...ealth Center (Tyler, TX) studied groups of patient...ho carry this genetic change were more likely to d...ria. , Infections with Mycobacterium tuberculosis,...
...t forms—beetles, flies, dragonflies, mosquitoes, g...rs—evolved? , Insects make up 75% of all species k...ly a result of a combination of one or more factor...ciation, an ability to adapt to new environments a... of extinction. Speciation, adaptation, and extinc...
Other Biology News:Key brain regulatory gene shows evolution in humans 2Key brain regulatory gene shows evolution in humans 3Key brain regulatory gene shows evolution in humans 4Gene increases risk of tuberculosis 2Adult stem cells aid recovery in animal model of cerebral palsy 2
Anti-Neurotensin Receptor Monoclonal Antibody, Unconjugated , Clone B-N6 from Cell Sciences
Goat Anti-Human HNF4 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human SART1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-IkappaB-alpha Monoclonal Antibody, Unconjugated, Clone 112B2 from Cell Signaling Technology
Biology Products: